Tacla M, Pontes J F
Arq Gastroenterol. 1980 Oct-Dec;17(4):203-9.
This work was developed in order to estimate, with objective methods, the pharmacodynamic activities of a new choleretic and antilithogenic drug, the cicloxilic acid. It was determined the changes of daily biliary flow and bile composition in 8 patients with biliary system surgical intervention and "T" (Kehr) tube inserted. The cicloxilic acid was given in the dose of 240 mg/day. The results showed, after treatment, an emphasized middle volume increase of the excreted bile, as well as a significant decrease of the biliary cholesterol, while pH and density maintained constants. The results corroborated the pharmacodynamic activities given to cicloxilic acid as a "true" choleretic to be utilized in clinic situations where it's wished a biliary flow increase and the possibility to avoid a cholesterol lithiasis or relieve consequent disturbances.
开展这项工作是为了用客观方法评估一种新型利胆和抗结石药物环氯噻嗪酸的药效学活性。对8例接受了胆道系统手术干预并插入“T”(凯尔)管的患者,测定其每日胆汁流量和胆汁成分的变化。环氯噻嗪酸的给药剂量为每日240毫克。结果显示,治疗后,排泄胆汁的中体积显著增加,同时胆汁胆固醇显著降低,而pH值和密度保持恒定。这些结果证实了环氯噻嗪酸作为一种“真正的”利胆剂的药效学活性,可用于希望增加胆汁流量以及避免胆固醇结石形成或缓解相关紊乱的临床情况。